Study assesses performance of biomarkers in diagnosing asthma, combining systematic review and validation cohort
NEJM Clinician highlighted a study that evaluated asthma biomarkers using a systematic review alongside a parallel prospective validation cohort.
“To assess the performance of biomarkers in the diagnosis of asthma, investigators conducted a systematic review and parallel prospective validation cohort.”— NEJM Clinician
NEJM Clinician, a digital resource that describes itself as delivering contextualised insights on impactful research in medicine, highlighted a study on asthma diagnosis in a post on X.
According to the post, investigators set out to assess the performance of biomarkers in the diagnosis of asthma. They conducted a systematic review and a parallel prospective validation cohort.
The post did not name the journal, and it did not report the biomarkers studied, the size of the cohort or the results. It directed readers to a linked page for the key results.
Original source
“To assess the performance of biomarkers in the diagnosis of asthma, investigators conducted a systematic review and parallel prospective validation cohort.”
— NEJM Clinician View the post on X